A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents / Susan E. SPRICH in Journal of Child Psychology and Psychiatry, 57-11 (November 2016)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 57-11 (November 2016) . - p.1218-1226 Titre : A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents Type de document : Texte imprimé et/ou numérique Auteurs : Susan E. SPRICH, Auteur ; Steven A. SAFREN, Auteur ; Daniel FINKELSTEIN, Auteur ; Jocelyn E. REMMERT, Auteur ; Paul HAMMERNESS, Auteur Article en page(s) : p.1218-1226 Langues : Anglais (eng) Mots-clés : ADHD  adolescence  behavior therapy  cognitive therapy Index. décimale : PER Périodiques Résumé : Objective To test cognitive behavioral therapy (CBT) for persistent attention-deficit hyperactivity disorder (ADHD) symptoms in a sample of medication-treated adolescents. Methods Forty-six adolescents (ages 14–18), with clinically significant ADHD symptoms despite stable medication treatment were randomly assigned to receive CBT for ADHD or wait list control in a cross-over design. Twenty-four were randomized to CBT, 22 to wait list, and 15 crossed-over from wait list to CBT. A blind independent evaluator (IE) rated symptom severity on the ADHD Current Symptom Scale, by adolescent and parent report, and rated each subject using the Clinical Global Impression Severity Scale (CGI), a global measure of distress and impairment. These assessments were performed at baseline, 4-months (post-CBT or post wait list), and 8-months (post-treatment for those originally assigned to the wait list condition and 4-month follow-up for those originally assigned to CBT). Trial Registration: http://clinicaltrials.gov/show/NCT01019252. Results Using all available data, mixed effects modeling, and pooling for the wait list cross-over, participants who received CBT received a mean score 10.93 lower on the IE-rated parent assessment of symptom severity (95% CI: ?12.93, ?8.93; p < .0001), 5.24 lower on the IE-rated adolescent assessment of symptom severity (95% CI: ?7.21, ?3.28; p < .0001), and 1.17 lower IE-rated CGI (95% CI: ?1.39, ?.94; p < .0001). Results were consistent across 100 multiple imputations (all p < .0001). There was a greater proportion of responders after CBT by parent (50% vs. 18%, p = .00) and adolescent (58% vs. 18% p = .02) report. Conclusions This study demonstrates initial efficacy of CBT for adolescents with ADHD who continued to exhibit persistent symptoms despite medications. En ligne : http://dx.doi.org/10.1111/jcpp.12549 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=295 [article] A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents [Texte imprimé et/ou numérique] / Susan E. SPRICH, Auteur ; Steven A. SAFREN, Auteur ; Daniel FINKELSTEIN, Auteur ; Jocelyn E. REMMERT, Auteur ; Paul HAMMERNESS, Auteur . - p.1218-1226. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 57-11 (November 2016) . - p.1218-1226 Mots-clés : ADHD  adolescence  behavior therapy  cognitive therapy Index. décimale : PER Périodiques Résumé : Objective To test cognitive behavioral therapy (CBT) for persistent attention-deficit hyperactivity disorder (ADHD) symptoms in a sample of medication-treated adolescents. Methods Forty-six adolescents (ages 14–18), with clinically significant ADHD symptoms despite stable medication treatment were randomly assigned to receive CBT for ADHD or wait list control in a cross-over design. Twenty-four were randomized to CBT, 22 to wait list, and 15 crossed-over from wait list to CBT. A blind independent evaluator (IE) rated symptom severity on the ADHD Current Symptom Scale, by adolescent and parent report, and rated each subject using the Clinical Global Impression Severity Scale (CGI), a global measure of distress and impairment. These assessments were performed at baseline, 4-months (post-CBT or post wait list), and 8-months (post-treatment for those originally assigned to the wait list condition and 4-month follow-up for those originally assigned to CBT). Trial Registration: http://clinicaltrials.gov/show/NCT01019252. Results Using all available data, mixed effects modeling, and pooling for the wait list cross-over, participants who received CBT received a mean score 10.93 lower on the IE-rated parent assessment of symptom severity (95% CI: ?12.93, ?8.93; p < .0001), 5.24 lower on the IE-rated adolescent assessment of symptom severity (95% CI: ?7.21, ?3.28; p < .0001), and 1.17 lower IE-rated CGI (95% CI: ?1.39, ?.94; p < .0001). Results were consistent across 100 multiple imputations (all p < .0001). There was a greater proportion of responders after CBT by parent (50% vs. 18%, p = .00) and adolescent (58% vs. 18% p = .02) report. Conclusions This study demonstrates initial efficacy of CBT for adolescents with ADHD who continued to exhibit persistent symptoms despite medications. En ligne : http://dx.doi.org/10.1111/jcpp.12549 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=295

---

1 (1 - 1 / 1)